Cangrelor intermediate 542-81-4

Cangrelor intermediate 542-81-4


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
China
Brand name
Bocimed
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
api, pharmaceutical, pharmaceutical intermediate, cangrelor
Category
Pharmaceutical Intermediates

Shanghai Bocimed Pharmaceutical Co., Ltd.

Membership
BIZ
Country / Year Established
China China / 2013
Business type
Manufacturer
Verified Certificate

7

Product name Cangrelor intermediate 542-81-4 Certification -
Category Pharmaceutical Intermediates Ingredients -
Keyword api , pharmaceutical , pharmaceutical intermediate , cangrelor Unit Size -
Brand name Bocimed Unit Weigh -
origin China Stock -
Supply type - HS code -

Product Information

We manufacture and provide Cangrelor intermediate with commercial capability

CAS 542-81-4

Purity is ≥ 98%

 

Cangrelor:

Cangrelor (trade name Kengreal in the US and Kengrexal in Europe) is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug[1] for intravenous application. 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Shanghai Bocimed Pharmaceutical Co., Ltd.

Country / Year Established
China China / 2013
Membership
BIZ
Business type
Manufacturer

7

President
Ms. Ying
Address
Building 9, No. 150, Cailun Road, Zhangjiang High-Tech Park, Shanghai, China
Product Category
Organic Intermediate
Year Established
2013
No. of Total Employees
51-100
Company introduction

Shanghai Bocimed Pharmaceutical Co., Ltd. is a high-tech enterprise specialized in drug research and development technical services, one of Shanghai high-tech enterprises, Shanghai integrity created enterprise, Shanghai SME innovation enterprises. The company started in 2007, formerly known as Shanghai MABCT Medicine Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in sales of raw materials, the drug import registration and China regional cooperation development. 

Bocimed is focus on the R&D and manufacture of pharmaceutical API and intermediates, has the R&D center in Shanghai with more than 2500m2, and the factory is located in Gansu Province, China. 

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more